Vasodilation
Vasodilation(血管扩张)
Vasodilation 相关产品(137)
- GC52023Alfuzosin-d7CAS: 1133386-93-2纯度: >99.00%
An internal standard for the quantification of alfuzosin
- GC52132N-desmethyl Diltiazem (hydrochloride)CAS: 130606-60-9纯度: >90.00%
An active metabolite of diltiazem
- GC52145Bradykinin (human, mouse, rat, bovine) (acetate)CAS: 6846-03-3纯度: >98.00%
An endogenous vasodilator
- GC52310L-Arginine-13C6 (hydrochloride)CAS: 201740-91-2纯度: >95.00% / >98.50%
An internal standard for the quantification of L-arginine
- GC52427Apelin-12 (human, mouse, rat, bovine) (acetate)纯度: >95.00%
An endogenous agonist of the APJ receptor
- GC92012MT-1207 (hydrochloride)纯度: >98.00%
MT-1207 (hydrochloride)是一种口服活性和选择性肾上腺素能α1和5-HT2A受体拮抗剂。MT-1207对α1A、α1B、α1D和5-HT2A的IC50分别小于0.1 nM、0.15 nM、1.40 nM和0.27 nM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC52006 | CB-096 | 108883-90-5 | >98.00% | |
An inhibitor of RAN translation | ||||
| GC52023 | Alfuzosin-d7 | 1133386-93-2 | >99.00% | |
An internal standard for the quantification of alfuzosin | ||||
| GC52034 | Quinaprilat | 82768-85-2 | >90.00% | |
An ACE inhibitor and active metabolite of quinapril | ||||
| GC52045 | N-desmethyl Azelastine | 47491-38-3 | >98.00% | |
An active metabolite of azelastine | ||||
| GC52132 | N-desmethyl Diltiazem (hydrochloride) | 130606-60-9 | >90.00% | |
An active metabolite of diltiazem | ||||
| GC52145 | Bradykinin (human, mouse, rat, bovine) (acetate) | 6846-03-3 | >98.00% | |
An endogenous vasodilator | ||||
| GC52310 | L-Arginine-13C6 (hydrochloride) | 201740-91-2 | >95.00% / >98.50% | |
An internal standard for the quantification of L-arginine | ||||
| GC52424 | Bradykinin Fragment (1-5) (trifluoroacetate salt) | - | >98.00% | |
A metabolite of bradykinin | ||||
| GC52427 | Apelin-12 (human, mouse, rat, bovine) (acetate) | - | >95.00% | |
An endogenous agonist of the APJ receptor | ||||
| GC52460 | tcY-NH2 (trifluoroacetate salt) | - | >98.00% | |
A peptide antagonist of PAR4 | ||||
| GC90022 | (±)-Norepinephrine-d6 (hydrochloride) | 1219803-04-9 | >99.00% | |
一种用于量化去甲肾上腺素的内部标准 | ||||
| GC90840 | 2-Chloroadenosine-5'-O-diphosphate (sodium salt) | 82927-78-4 | >95.00% | |
ADP的衍生物。 | ||||
| GC91065 | (±)13,14-EDT | 355016-19-2 | >98.00% | |
一种肾上腺酸的代谢产物。 | ||||
| GC91067 | (±)16,17-EDT | 351533-79-4 | >98.00% | |
一种肾上腺酸的代谢产物。 | ||||
| GC91109 | 17β-Estradiol 3-O-Sulfate (sodium salt) | 4999-79-5 | >98.00% | |
17β-雌二醇的一种不活性代谢产物。 | ||||
| GC91223 | Brain Natriuretic Peptide-32 (rat) (acetate) | - | >98.00% | |
一种利钠肽。 | ||||
| GC92012 | MT-1207 (hydrochloride) | - | >98.00% | |
MT-1207 (hydrochloride)是一种口服活性和选择性肾上腺素能α1和5-HT2A受体拮抗剂。MT-1207对α1A、α1B、α1D和5-HT2A的IC50分别小于0.1 nM、0.15 nM、1.40 nM和0.27 nM。 | ||||